President Donald Trump’s choice to lead America’s Food and Drug Administration (FDA) is Dr. Marty Makary, a surgeon who gained international attention during thePresident Donald Trump’s choice to lead America’s Food and Drug Administration (FDA) is Dr. Marty Makary, a surgeon who gained international attention during the

WSJ: Trump's new FDA pick is a disaster

2026/05/04 02:29
3 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

President Donald Trump’s choice to lead America’s Food and Drug Administration (FDA) is Dr. Marty Makary, a surgeon who gained international attention during the COVID-19 pandemic for his opposition to vaccine mandates. On paper, Makary seems like a great choice for the job, but a conservative newspaper is reporting “soap opera”-level drama associated with his tenure.

“Has any Trump administration official caused more political headaches for the president than Marty Makary?” wrote Allysia Finley of The Wall Street Journal on Sunday. “His Food and Drug Administration has turned into a soap opera, with real lives hanging in the balance.”

To illustrate this point, Finley described how "in public interviews, [Makary] boasts about accelerating access to gene therapies and rare-disease drugs, even as he and his deputies block them." Describing Makary as “slicker than a pharmaceutical salesman,” the Journal reporter observed that “my sources say that patience with Dr. Makary is wearing thin among Republicans in Congress and White House officials."

Since taking office, Makary has rejected rare-disease and cancer drugs, a gene therapy for Huntington’s Disease and various other medicines that had demonstrably improved or even saved lives. He has also been accused of allowing conflicts of interest to override his detached clinical judgment.

“Members of Congress are also investigating whistleblower complaints of retaliation by agency leadership against FDA staff who have recommended approvals of drugs with which Dr. Makary and his left-hand man, Vinay Prasad, disagreed,” Finley reported. “Dr. Prasad is a Bernie Sanders acolyte whom the commissioner tapped to lead the FDA’s biologics and gene-therapy division.”

Finley also quoted a Republican, Sen. Ron Johnson of Wisconsin, as saying that “the stories are so outrageous. It just appears that they're looking for excuses to say no." Johnson also reported rumors that the FDA has kept a “blacklist” of companies that “make too much noise.”

Finely concluded, "It's time for Mr. Trump to pull the plug on the Makary show."

Although not mentioned in her editorial, the FDA is also under fire for seeming to pull back from its responsibilities to protect food. Under Makary’s tenure, the FDA announced it would no longer engage in routine food inspections, describing that job as superfluous and instead arguing federal inspectors should offload all of those responsibilities to local authorities.

"There's so much work to go around. And us duplicating their work just doesn't make sense," a former FDA official explained to CBS News at the time.

The FDA has also been criticized for incorrectly saying that COVID vaccines have caused child deaths, a policy that Dr. Celine Grounder of KFF Health News denounced for allegedly endangering the public.

“What is unfolding inside the FDA is not a narrow dispute over covid vaccines,” Grounder argued. “It is an attempt, according to critics and vaccine scientists, to rewrite the rules governing the entire U.S. vaccine system — how risks are weighed, how benefits are proved, and how quickly lifesaving shots reach the public.”

Grounder concluded, “Former agency leaders warn that if these changes take hold, the consequences could be lasting: fewer vaccines, slower updates, weakened public trust, and more preventable outbreaks.”

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Opportunità di mercato
Logo OFFICIAL TRUMP
Valore OFFICIAL TRUMP (TRUMP)
$1.568
$1.568$1.568
-4.50%
USD
Grafico dei prezzi in tempo reale di OFFICIAL TRUMP (TRUMP)

Get Covered, Share 1M USDT

Get Covered, Share 1M USDTGet Covered, Share 1M USDT

Higher VVIP tiers, higher compensation odds.

Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

The post One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight appeared on BitcoinEthereumNews.com. Frank Sinatra’s The World We Knew returns to the Jazz Albums and Traditional Jazz Albums charts, showing continued demand for his timeless music. Frank Sinatra performs on his TV special Frank Sinatra: A Man and his Music Bettmann Archive These days on the Billboard charts, Frank Sinatra’s music can always be found on the jazz-specific rankings. While the art he created when he was still working was pop at the time, and later classified as traditional pop, there is no such list for the latter format in America, and so his throwback projects and cuts appear on jazz lists instead. It’s on those charts where Sinatra rebounds this week, and one of his popular projects returns not to one, but two tallies at the same time, helping him increase the total amount of real estate he owns at the moment. Frank Sinatra’s The World We Knew Returns Sinatra’s The World We Knew is a top performer again, if only on the jazz lists. That set rebounds to No. 15 on the Traditional Jazz Albums chart and comes in at No. 20 on the all-encompassing Jazz Albums ranking after not appearing on either roster just last frame. The World We Knew’s All-Time Highs The World We Knew returns close to its all-time peak on both of those rosters. Sinatra’s classic has peaked at No. 11 on the Traditional Jazz Albums chart, just missing out on becoming another top 10 for the crooner. The set climbed all the way to No. 15 on the Jazz Albums tally and has now spent just under two months on the rosters. Frank Sinatra’s Album With Classic Hits Sinatra released The World We Knew in the summer of 1967. The title track, which on the album is actually known as “The World We Knew (Over and…
Condividi
BitcoinEthereumNews2025/09/18 00:02
Not a loophole: Singapore AI export controls let China tap US AI legally

Not a loophole: Singapore AI export controls let China tap US AI legally

American AI technology is reaching Chinese tech giants through a route that US export controls were never designed to close: Singapore. The city-state sits outside
Condividi
The Cryptonomist2026/07/10 14:46
LIST: Bayanihan initiatives amid soaring oil prices

LIST: Bayanihan initiatives amid soaring oil prices

Here is a running list of initiatives and efforts you can support to help sectors affected by the oil price hikes
Condividi
Rappler2026/04/02 18:14

Record Ads, Stock Down 7%

Record Ads, Stock Down 7%Record Ads, Stock Down 7%

Jul 29: Meta earnings face the market's question.